Steve Schonfeld’s cbdMD YCBD Stock Holding History

Steve Schonfeld’s Portfolio YCBD Stock Details YCBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-54	Closed	-$20K	–	3063
2022 Q1	$20K	Buy	+54	New	+$18.2K	﹤0.01%	2398

Other funds holding YCBD

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

CIM

Cambria Investment Management Manhattan Beach, California $2.02B AUM 35.98% 1-Year Est. Return

Steve Schonfeld's YCBD Position: Q2 2022 in Review

Steve Schonfeld sold out of cbdMD (YCBD) in Q2 2022, closing a stake of 54 shares — an estimated $20K sold.

Steve Schonfeld first reported a position in YCBD in Q1 2022 and held it in 1 quarter. The position peaked at $20K in Q1 2022. 51 funds tracked by Wall St. Rank hold YCBD as of Q2 2022.

Steve Schonfeld reported no remaining cbdMD position as of Q2 2022 after selling out during the quarter.
Steve Schonfeld sold 54 cbdMD shares in Q2 2022, an estimated $20K.
Steve Schonfeld first reported a position in cbdMD in Q1 2022 and held it in 1 quarter.
Steve Schonfeld's cbdMD position peaked at $20K in Q1 2022.
51 funds tracked by Wall St. Rank held cbdMD as of Q2 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.